HKEX Filings
-
May 5, 2023
NOTIFICATION LETTER AND REQUEST FORM TO NON-REGISTERED SHAREHOLDERS
-
May 5, 2023
FORM OF PROXY FOR USE AT ANNUAL GENERAL MEETING
-
May 5, 2023
NOTICE OF ANNUAL GENERAL MEETING
-
May 5, 2023
(1). PROPOSED GRANT OF GENERAL MANDATES TO REPURCHASE SHARES AND TO ISSUE NEW SHARES; (2). PROPOSED GRANT OF OPTIONS AND RSUS; (3). PROPOSED RE-ELECTION OF THE RETIRING DIRECTORS; (4). PROPOSED RE-APPOINTMENT OF AUDITOR; AND (5). NOTICE OF ANNUAL GENERAL MEETING
-
May 5, 2023
Monthly Return of Equity Issuer on Movements in Securities for the Month ended April 30, 2023
-
Apr 20, 2023
NOTIFICATION LETTER AND REQUEST FORM TO NON-REGISTERED SHAREHOLDERS
-
Apr 11, 2023
2022 Annual Report
-
Apr 11, 2023
GRANT OF OPTIONS PURSUANT TO THE POST-IPO SHARE OPTION PLAN AND GRANT OF RSUS PURSUANT TO THE RSU SCHEME
-
Apr 4, 2023
Monthly Return of Equity Issuer on Movements in Securities for the Month ended March 31, 2023
-
Mar 31, 2023
CHANGE OF JOINT COMPANY SECRETARY
-
Mar 29, 2023
ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2022
-
Mar 16, 2023
DATE OF BOARD MEETING
-
Mar 3, 2023
Monthly Return of Equity Issuer on Movements in Securities for the Month ended February 28, 2023
-
Feb 20, 2023
INSIDE INFORMATION - CLOVER ENTERS INTO EXCLUSIVE AGREEMENT TO COMMERCIALIZE QUADRIVALENT SEASONAL INFLUENZA VACCINE IN MAINLAND CHINA
-
Feb 14, 2023
VOLUNTARY ANNOUNCEMENT - CLOVER LAUNCHES COVID-19 BOOSTER VACCINE IN THE PEOPLE'S REPUBLIC OF CHINA
-
Feb 3, 2023
Monthly Return of Equity Issuer on Movements in Securities for the Month ended January 31, 2023
-
Jan 16, 2023
INSIDE INFORMATION - CLOVER PROVIDES UPDATES ON COVID-19 VACCINE COMMERCIAL LAUNCH AND STRATEGIC PRIORITIES IN 2023
-
Jan 4, 2023
Monthly Return of Equity Issuer on Movements in Securities for the Month ended December 31, 2022
-
Dec 30, 2022
Remuneration Committee - Terms of Reference
-
Dec 16, 2022
(1) GRANT OF OPTIONS AND RSUS (2) AMENDMENT TO VESTING SCHEDULE OF PREVIOUSLY GRANTED RSUS AND (3) AMENDMENT TO THE TRUST DEED